Summary

whalecover54 Users

  • A phase I/II test of brentuximab vedotin plus rituximab as frontline treatment with regard to patients with immunosuppression-associated CD30+ and/or EBV + lymphomas.
Offline Offline
Posts:
0 (0 per day)
Age:
N/A
Date Registered:
2025-08-11, 11:21:51
Local Time:
2025-08-31, 13:53:00
Last Active:
2025-08-11, 18:41:57
Signature:
n could regulate serum cholesterol level, promote immune function, and improve intestinal oxidative status and morphology in broilers. The antibacteri